Literature DB >> 2789497

Night blindness and conjunctival xerosis caused by vitamin A deficiency in patients with cystic fibrosis.

R J Rayner1, J C Tyrrell, E J Hiller, C Marenah, M A Neugebauer, S A Vernon, G Brimlow.   

Abstract

Forty three patients with cystic fibrosis, aged 8-44 years (median 16 years), were examined for evidence of vitamin A deficiency. Eight patients had abnormal dark adaptation tests and three had conjunctival xerosis. Serum vitamin A and retinol binding protein concentrations were significantly lower in the affected patients who were also more likely to have abnormal liver function tests. Five patients were treated with 100,000-200,000 IU water miscible vitamin A orally and their daily vitamin supplements were increased to maintain normal concentrations. In four patients dark adaptation tests were repeated. Three were normal, but one patient required three further doses of water miscible vitamin A and a daily supplement of 12,000 IU vitamin A before her dark adaptation threshold returned to normal. Adolescents with cystic fibrosis are liable to develop night blindness and conjunctival xerosis, particularly if they have liver disease or fail to take daily vitamin supplements.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2789497      PMCID: PMC1792522          DOI: 10.1136/adc.64.8.1151

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  16 in total

1.  Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period.

Authors:  H SHWACHMAN; L L KULCZYCKI
Journal:  AMA J Dis Child       Date:  1958-07

2.  Bulging fontanelle as presenting sign in cystic fibrosis. Vitamin A metabolism and effect on cerebrospinal fluid pressure.

Authors:  R S Abernathy
Journal:  Am J Dis Child       Date:  1976-12

Review 3.  The determination of vitamin A and some aspects of its distribution, mobilization and transport in health and disease.

Authors:  B A Underwood
Journal:  World Rev Nutr Diet       Date:  1974       Impact factor: 0.575

4.  Depressed plasma retinol-binding protein levels in cystic fibrosis.

Authors:  F R Smith; B A Underwood; C R Denning; A Varma; D S Goodman
Journal:  J Lab Clin Med       Date:  1972-09

5.  Vitamin A deficiency with xerophthalmia and night blindness in cystic fibrosis.

Authors:  R A Petersen; V S Petersen; R M Robb
Journal:  Am J Dis Child       Date:  1968-12

Review 6.  Multiple functions of vitamin A.

Authors:  G Wolf
Journal:  Physiol Rev       Date:  1984-07       Impact factor: 37.312

Review 7.  The interaction of vitamin A and zinc: implications for human nutrition.

Authors:  N W Solomons; R M Russell
Journal:  Am J Clin Nutr       Date:  1980-09       Impact factor: 7.045

8.  Vitamin status in treated patients with cystic fibrosis.

Authors:  P J Congden; G Bruce; M M Rothburn; P C Clarke; J M Littlewood; J Kelleher; M S Losowsky
Journal:  Arch Dis Child       Date:  1981-09       Impact factor: 3.791

Review 9.  Cystic fibrosis and malnutrition.

Authors:  H P Chase; M A Long; M H Lavin
Journal:  J Pediatr       Date:  1979-09       Impact factor: 4.406

10.  Scotopic thresholds and plasma retinol in cystic fibrosis.

Authors:  A B Fulton; R M Hansen; B A Underwood; H Shwachman; D C Barg
Journal:  Invest Ophthalmol Vis Sci       Date:  1982-09       Impact factor: 4.799

View more
  12 in total

Review 1.  Fear of the dark in children: is stationary night blindness the cause?

Authors:  Sikander S Sidiki; Ruth Hamilton; Gordon N Dutton
Journal:  BMJ       Date:  2003-01-25

2.  Why bother to take vitamins?

Authors:  Alison Morton
Journal:  J R Soc Med       Date:  2011-07       Impact factor: 5.344

3.  Role of electroretinography in the assessment of retinal function as an indicator of vitamin A status.

Authors:  I Tsinopoulos; S Nousia-Arvanitakis; A Galli-Tsinopoulou; N Roubies; K Tentzidou; M Xefteri; N Stangos
Journal:  Doc Ophthalmol       Date:  2000-11       Impact factor: 2.379

4.  Retinol binding protein status in relation to ocular surface changes in patients with cystic fibrosis treated with daily vitamin A supplements.

Authors:  Malgorzata Mrugacz; Jolanta Tobolczyk; Alina Minarowska
Journal:  Eur J Pediatr       Date:  2004-11-20       Impact factor: 3.183

Review 5.  Nutritional management of cystic fibrosis.

Authors:  A MacDonald
Journal:  Arch Dis Child       Date:  1996-01       Impact factor: 3.791

6.  Ocular findings in cystic fibrosis patients receiving vitamin A supplementation.

Authors:  J C Morkeberg; C Edmund; J U Prause; S Lanng; C Koch; K F Michaelsen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-11       Impact factor: 3.117

7.  Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis.

Authors:  Drucy Borowitz; Karen A Robinson; Margaret Rosenfeld; Stephanie D Davis; Kathryn A Sabadosa; Stephanie L Spear; Suzanne H Michel; Richard B Parad; Terry B White; Philip M Farrell; Bruce C Marshall; Frank J Accurso
Journal:  J Pediatr       Date:  2009-12       Impact factor: 4.406

8.  ERGs in children with pancreatic enzyme insufficient and pancreatic enzyme sufficient cystic fibrosis.

Authors:  Andrew Whatham; Catherine Suttle; Caron Blumenthal; Jane Allen; Kevin Gaskin
Journal:  Doc Ophthalmol       Date:  2009-03-03       Impact factor: 2.379

Review 9.  Pathophysiology of cystic fibrosis and drugs used in associated digestive tract diseases.

Authors:  Adriana Haack; Giselle Gonçalves Aragão; Maria Rita Carvalho Garbi Novaes
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

10.  An atypical presentation of cystic fibrosis: a case report.

Authors:  Deepak Joshi; Anil Dhawan; Alistair J Baker; Michael A Heneghan
Journal:  J Med Case Rep       Date:  2008-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.